ERIKA SPENCER: Open Payments
NPI 1689814147 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$750 in 26 payments from 13 companies in 2025. Trend: 2023 $782 · 2024 $650 · 2025 $750
Food & beverage: $750
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $334 |
| PFIZER INC. | 4 | $92 |
| Novo Nordisk Inc | 4 | $69 |
| GlaxoSmithKline, LLC. | 3 | $59 |
| UCB, Inc. | 1 | $31 |
| Amgen Inc. | 2 | $31 |
| ABBVIE INC. | 1 | $24 |
| Neurelis, Inc. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: AIRSUPRA, BREZTRI, PREVNAR 20, Rybelsus, JARDIANCE, TRELEGY ELLIPTA, Briviact, REPATHA.
Industry payments across LA — which companies pay providers there.
